Literature DB >> 23460557

Treatment of hypertrophic scars using laser and laser assisted corticosteroid delivery.

Jill S Waibel1, Adam J Wulkan, Peter R Shumaker.   

Abstract

BACKGROUND AND OBJECTIVES: Hypertrophic scars and contractures are common following various types of trauma and procedures despite skilled surgical and wound care. Following ample time for healing and scar maturation, many millions of patients are burdened with persistent symptoms and functional impairments. Cutaneous scars can be complex and thus the approach to therapy is often multimodal. Intralesional corticosteroids have long been a staple in the treatment of hypertrophic and restrictive scars. Recent advances in laser technology and applications now provide additional options for improvements in function, symptoms, and cosmesis. Fractional ablative lasers create zones of ablation at variable depths of the skin with the subsequent induction of a wound healing and collagen remodeling response. Recent reports suggest these ablative zones may also be used in the immediate post-operative period to enhance delivery of drugs and other substances. We present a case series evaluating the efficacy of a novel combination therapy that incorporates the use of an ablative fractional laser with topically applied triamcinolone acetonide suspension in the immediate post-operative period.
METHODS: This is a prospective case series including 15 consecutive subjects with hypertrophic scars resulting from burns, surgery or traumatic injuries. Subjects were treated according to typical institutional protocol with three to five treatment sessions at 2- to 3-month intervals consisting of fractional ablative laser treatment and immediate post-operative topical application of triamcinolone acetonide suspension at a concentration of 10 or 20 mg/ml. Three blinded observers evaluated photographs taken at baseline and six months after the final treatment session. Scores were assigned using a modified Manchester quartile score to evaluate enhancements in dyschromia, hypertrophy, texture, and overall improvement. LIMITATIONS: Small sample size and lack of a control arm.
RESULTS: Combination same session laser therapy and immediate post-operative corticosteroid delivery resulted in average overall improvement of 2.73/3.0. Dyschromia showed the least amount of improvement while texture showed the most improvement.
CONCLUSION: Combination same-session therapy with ablative fractional laser-assisted delivery of triamcinolone acetonide potentially offers an efficient, safe and effective combination therapy for challenging hypertrophic and restrictive cutaneous scars.
Copyright © 2013 Wiley Periodicals, Inc.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23460557     DOI: 10.1002/lsm.22120

Source DB:  PubMed          Journal:  Lasers Surg Med        ISSN: 0196-8092            Impact factor:   4.025


  21 in total

Review 1.  Laser-assisted drug delivery in dermatology: from animal models to clinical practice.

Authors:  Faisal R Ali; Firas Al-Niaimi
Journal:  Lasers Med Sci       Date:  2015-12-22       Impact factor: 3.161

Review 2.  Up-to-date approach to manage keloids and hypertrophic scars: a useful guide.

Authors:  Anna I Arno; Gerd G Gauglitz; Juan P Barret; Marc G Jeschke
Journal:  Burns       Date:  2014-04-24       Impact factor: 2.744

3.  Invited Discussion on: Treatment of Scars with Laser-Assisted Delivery of Growth Factors and Vitamin C: A Comparative, Randomised, Double-blind, Early Clinical Trial.

Authors:  Luís Ricardo Martinhão Souto; Mariam Patrícia Auada Souto
Journal:  Aesthetic Plast Surg       Date:  2021-05-10       Impact factor: 2.326

Review 4.  Treatment of keloid scars using light-, laser- and energy-based devices: a contemporary review of the literature.

Authors:  E Forbat; F R Ali; F Al-Niaimi
Journal:  Lasers Med Sci       Date:  2017-10-18       Impact factor: 3.161

5.  Towards the Development of a Device for Assessing the Pliability of Burn Scars.

Authors:  Francesco Dalle Mura; Lapo Governi; Rocco Furferi; Marta Cervo; Luca Puggelli
Journal:  Front Bioeng Biotechnol       Date:  2022-06-20

6.  Hypertrophic Scar Outcomes in Fractional Laser Monotherapy Versus Fractional Laser-Assisted Topical Corticosteroid Delivery: A Randomized Clinical Trial.

Authors:  Woraphong Manuskiatti; Arisa Kaewkes; Chadakan Yan; Janice Natasha Ng; Joshua Zev Glahn; Rungsima Wanitphakdeedecha
Journal:  Acta Derm Venereol       Date:  2021-03-17       Impact factor: 3.875

Review 7.  A comprehensive evidence-based review on the role of topicals and dressings in the management of skin scarring.

Authors:  G P Sidgwick; D McGeorge; A Bayat
Journal:  Arch Dermatol Res       Date:  2015-06-05       Impact factor: 3.017

8.  Abnormalities in collagen composition may contribute to the pathogenesis of hemorrhoids: morphometric analysis.

Authors:  Y Y Nasseri; E Krott; K M Van Groningen; M Berho; M C Osborne; S Wollman; E G Weiss; S D Wexner
Journal:  Tech Coloproctol       Date:  2014-11-09       Impact factor: 3.781

9.  Percutaneous bone marrow transplantation using fractional ablative Erbium:YAG laser.

Authors:  Luis Rodriguez-Menocal; Marcela Salgado; Stephen Davis; Jill Waibel; Arsalan Shabbir; Audrey Cox; Evangelos V Badiavas
Journal:  PLoS One       Date:  2014-03-25       Impact factor: 3.240

Review 10.  Skin resurfacing procedures: new and emerging options.

Authors:  Mathew M Loesch; Ally-Khan Somani; Melanie M Kingsley; Jeffrey B Travers; Dan F Spandau
Journal:  Clin Cosmet Investig Dermatol       Date:  2014-08-28
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.